Form 4 for BSX Boston Scientific
Accepted 2026-08-05 16:15:51 ET · period of report 2026-08-03 · accession 0001225208-26-006950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 16:15 | 2026-08-03 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | P - Purchase | $48.33 | +186.2K | 1.59M | +13% | +$9.00M | |
| I | 2026-08-05 16:15 | 2026-08-03 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | I - Discretionary | $48.43 | +22.1K | 22.1K | New | +$1.07M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | P | A | 186,240 | $48.33 | 1,590,024 | D | — | — | (F1) Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.87 to $48.47, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2026-08-03 | I | A | 22,119 | $48.43 | 22,119 | I By 401(k) | — | — | (F2) Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock. |